# SAPHNELO

NDC: 0310-3040
Generic name: Anifrolumab-fnia
Labeler / Manufacturer: AstraZeneca Pharmaceuticals LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20210730

FDA application: BLA761123

## Active ingredients

- ANIFROLUMAB: 300 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0310-3040"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0310-3040
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d6203302-2128-41a7-b0b4-0e6c0704d4dc